ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.1K |
1.8M |
3 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
4.1K
|
1.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Charlie and the once in a lifetime post!
|
|
JamesTas
|
52 |
15K |
4 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
52
|
15K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Application for quotation of securities - PAR
|
|
JamesTas
|
14 |
3.9K |
3 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
14
|
3.9K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Charlie and the once in a lifetime post!
|
|
JamesTas
|
52 |
15K |
3 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
52
|
15K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
JamesTas
|
4.1K |
1.8M |
3 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
4.1K
|
1.8M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
lowest ever
|
|
JamesTas
|
5 |
2.6K |
12 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
5
|
2.6K
|
12
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
JamesTas
|
21K |
7.1M |
3 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
21K
|
7.1M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
JamesTas
|
104 |
29K |
9 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
29K
|
9
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
44K |
0 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
117
|
44K
|
0
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
44K |
6 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
117
|
44K
|
6
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
44K |
0 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
117
|
44K
|
0
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
44K |
2 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
117
|
44K
|
2
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
44K |
1 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
117
|
44K
|
1
|
|
ASX - By Stock
|
PAR Medicine |
Re:
Why Zilosul could be a golden goose!!
|
|
JamesTas
|
117 |
44K |
4 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
117
|
44K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.7M |
7 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
4.2K
|
3.7M
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.7M |
5 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
4.2K
|
3.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
JamesTas
|
236 |
88K |
7 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
236
|
88K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
484 |
156K |
6 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
484
|
156K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
484 |
156K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
484
|
156K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
JamesTas
|
670 |
252K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
670
|
252K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
JamesTas
|
46 |
16K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
16K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
JamesTas
|
46 |
16K |
8 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
16K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
484 |
156K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
484
|
156K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
484 |
156K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
484
|
156K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
484 |
156K |
20 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
484
|
156K
|
20
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
JamesTas
|
484 |
156K |
23 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
484
|
156K
|
23
|
|
ASX - By Stock
|
PAR |
Re:
Resolution of lumbar bone marrow oedema
|
|
JamesTas
|
76 |
35K |
16 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
76
|
35K
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.7M |
11 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4.2K
|
3.7M
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
JamesTas
|
4.2K |
3.7M |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4.2K
|
3.7M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Final Director's Interest Notice
|
|
JamesTas
|
19 |
5.7K |
5 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
19
|
5.7K
|
5
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Half Yearly Report and Accounts
|
|
JamesTas
|
24 |
5.7K |
2 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
24
|
5.7K
|
2
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Half Yearly Report and Accounts
|
|
JamesTas
|
24 |
5.7K |
10 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
24
|
5.7K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Half Yearly Report and Accounts
|
|
JamesTas
|
37 |
13K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
37
|
13K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
236 |
78K |
4 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
236
|
78K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
236 |
78K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
236
|
78K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
JamesTas
|
236 |
78K |
13 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
236
|
78K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
JamesTas
|
974 |
319K |
12 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
974
|
319K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Successful completion of Retail Entitlement Offer
|
|
JamesTas
|
95 |
28K |
5 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
95
|
28K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
AGM Meeting
|
|
JamesTas
|
92 |
33K |
27 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
92
|
33K
|
27
|
|
ASX - By Stock
|
PAR |
Re:
If the claim is....then why ?
|
|
JamesTas
|
26 |
6.1K |
6 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
26
|
6.1K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2023 AGM Chairman Address
|
|
JamesTas
|
18 |
5.7K |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
18
|
5.7K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2023 AGM Chairman Address
|
|
JamesTas
|
18 |
5.7K |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
18
|
5.7K
|
2
|
|
ASX - By Stock
|
FRX |
FRX Shop front
|
|
JamesTas
|
1 |
574 |
2 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
1
|
574
|
2
|
|
ASX - By Stock
|
PAR |
Re:
AGM 2024 - QUESTIONS
|
|
JamesTas
|
151 |
46K |
1 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
151
|
46K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
JamesTas
|
40 |
12K |
0 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
40
|
12K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
JamesTas
|
508 |
123K |
1 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
508
|
123K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
A 101 on PAR options...
|
|
JamesTas
|
44 |
13K |
2 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
44
|
13K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
JamesTas
|
62 |
21K |
2 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
62
|
21K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm to Recommence Trading
|
|
JamesTas
|
10 |
4.2K |
6 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
10
|
4.2K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
JamesTas
|
108 |
29K |
4 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
108
|
29K
|
4
|
|